Last reviewed · How we verify

NCT05481398: NPWT

A Randomized Controlled Trial Evaluating the Role of Negative Pressure Wound Therapy (NPWT) for Incisional Surgical Site Infections in Patients Undergoing Hepatopancreatobiliary Surgery

Completed NA Last updated 1 August 2022
What this trial tests

NA trial testing Negative Pressure Wound Therapy in Hepatobiliary Disease in 46 participants. Completed in 1 July 2022.

Timeline
6 March 2021
Primary endpoint
1 July 2022
1 July 2022

Quick facts

Lead sponsorMurk Niaz
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment46
Start date6 March 2021
Primary completion1 July 2022
Estimated completion1 July 2022
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Murk Niaz

Who can join

18 and older, any sex, with Hepatobiliary Disease or Hepatobiliary Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the rates of incisional surgical site infections (iSSIs) within 7 days of hepatopancreatobiliary (HPB) surgery using negative pressure wound therapy (NWPT) versus using standard sterile gauze dressing.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Negative Pressure Wound Therapy

Trials testing the same drug.

Other recruiting trials for Hepatobiliary Disease

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05481398.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing